With 2.04 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.21 million shares. During the session, the Uranium company that operates in wider Energy sector, reached to the highest price of $2.39 whereas the lowest price it dropped to was $2.3. The 52-week range on UROY shows that it touched its highest point at $3.76 and its lowest point at $1.86 during that stretch. It currently has a 1-year price target of $4.52. Beta for the stock currently stands at 1.45.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of UROY was up-trending over the past week, with a rise of 7.31%, but this was down by -1.67% over a month. Three-month performance dropped to -8.56% while six-month performance rose 2.62%. The stock lost -8.91% in the past year, while it has gained 7.31% so far this year. A look at the trailing 12-month EPS for UROY yields 0.04 with Next year EPS estimates of 0.07. For the next quarter, that number is 0.01. This implies an EPS growth rate of -87.93% for this year and 851.19% for next year.
Float and Shares Shorts:
At present, 124.44 million UROY shares are outstanding with a float of 110.45 million shares on hand for trading. On 2024-11-29, short shares totaled 7.7 million, which was 673.0 higher than short shares on 1730332800. In addition to Mr. Scott Eric Melbye as the firm’s CEO, President & Director, Ms. Josephine Man serves as its CFO & Corporate Secretary.
Institutional Ownership:
Through their ownership of 0.22799999 of UROY’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-07-31, UROY reported revenue of $10903000.0 and operating income of $122000.0. The EBITDA in the recently reported quarter was -$17000.0 and diluted EPS was $0.0.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With UROY analysts setting a high price target of 11.03 and a low target of 4.982, the average target price over the next 12 months is 8.006. Based on these targets, UROY could surge 369.36% to reach the target high and rise by 112.0% to reach the target low. Reaching the average price target will result in a growth of 240.68% from current levels.
Analysts have provided yearly estimates in a range of $0.07907091 being high and $0.0597825 being low. For UROY, this leads to a yearly average estimate of $0.06942984.
